Literature DB >> 10964078

Duration of rhythmic EEG patterns in neonates: new evidence for clinical and prognostic significance of brief rhythmic discharges.

A J Oliveira1, M L Nunes, L M Haertel, F M Reis, J C da Costa.   

Abstract

OBJECTIVE: This study aimed at identifying the characteristics - especially the duration - of rhythmic discharges in neonatal EEG, and their association with clinical neonatal problems. Specifically, we aimed at testing the diagnostic and prognostic validity of using 10 s as minimal duration for defining electroencephalographic seizures. DESIGN AND METHODS: The polysomnographies of 340 neonates were reviewed, and episodes of rhythmic discharges were identified, analyzed, and quantified. The study sample was divided into 3 groups: one in which the maximal duration of rhythmic discharges was shorter than 10 s (brief rhythmic discharges, BRD), a second one in which there were rhythmic discharges longer than 10 s (long rhythmic discharges, LRD), and finally a group in which no rhythmic discharge was found (No-RD). These 3 groups of subjects were compared for the baseline and outcome clinical data.
RESULTS: From the 340 neonates studied, 210 did not present any form of rhythmic discharge, 67 (19. 7%) had only BRD episodes, and 63 (18.5%) had at least one LRD episode. Prevalence of rhythmic discharges was low among healthy full term newborns, and was significantly higher among preterm and high-risk newborns. Electrophysiological characteristics of rhythmic discharges did not differ between healthy neonates and high-risk ones. Accompanying clinical manifestations were present in 26.3% of the LRD group, but also in 15.9% of the BRD group. The presence of BRD was significantly associated with leukomalacia and with hypoglycemia in the cross-sectional analysis of baseline data, and with an increased risk for abnormal neurodevelopmental outcome after a mean follow-up period of 47 months (adjusted relative risk=4.90, P<0.01).
CONCLUSIONS: The present data demonstrate an association between BRD and clinical history of hypoxic-ischemic encephalopathy, especially when complicated by leukomalacia, and also with a prognosis of increased risk for abnormal neurodevelopmental outcome. The clinical and prognostic significance of isolated BRD justifies the need to include these brief episodes in future studies of neonatal seizures.

Entities:  

Mesh:

Year:  2000        PMID: 10964078     DOI: 10.1016/s1388-2457(00)00380-1

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  7 in total

Review 1.  Role of cerebral function monitoring in the newborn.

Authors:  L S de Vries; L Hellström-Westas
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-05       Impact factor: 5.747

2.  Amplitude-integrated electroencephalography in full-term newborns without severe hypoxic-ischemic encephalopathy: case series.

Authors:  Damjan Osredkar; Metka Derganc; Darja Paro-Panjan; David Neubauer
Journal:  Croat Med J       Date:  2006-04       Impact factor: 1.351

Review 3.  Neonatal seizures and status epilepticus.

Authors:  Nicholas S Abend; Courtney J Wusthoff
Journal:  J Clin Neurophysiol       Date:  2012-10       Impact factor: 2.177

4.  Technical standards for recording and interpretation of neonatal electroencephalogram in clinical practice.

Authors:  Perumpillichira J Cherian; Renate M Swarte; Gerhard H Visser
Journal:  Ann Indian Acad Neurol       Date:  2009-01       Impact factor: 1.383

Review 5.  Clinical management of seizures in newborns : diagnosis and treatment.

Authors:  Linda G M van Rooij; Marcel P H van den Broek; Carin M A Rademaker; Linda S de Vries
Journal:  Paediatr Drugs       Date:  2013-02       Impact factor: 3.022

Review 6.  Neuromonitoring in Neonatal-Onset Epileptic Encephalopathies.

Authors:  Regina Trollmann
Journal:  Front Neurol       Date:  2021-02-02       Impact factor: 4.003

Review 7.  BIRDs (Brief Potentially Ictal Rhythmic Discharges) watching during EEG monitoring.

Authors:  Ji Yeoun Yoo
Journal:  Front Neurol       Date:  2022-08-23       Impact factor: 4.086

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.